Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine. - Serra L; Webber C; Burman C; Bueti P; Gorruso M; Mather S (Vaccine, 2022)